Recurrent Glioblastoma Multiforme (GBM) Clinical Trials in Shanghai

A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)